Surgery Partners will announce Q1 2025 results on May 12, 2025, with a conference call at 8:30 a.m. ET.
Quiver AI Summary
Surgery Partners, Inc., a prominent operator of short-stay surgical facilities, announced it will release its first quarter 2025 financial results on May 12, 2025, before the market opens. Following the release, there will be a conference call at 8:30 a.m. Eastern Time, accessible via domestic and international phone numbers provided in the announcement. A replay of the call will be available shortly after and until May 26, 2025, along with a simultaneous webcast on their Investor Relations website. Founded in 2004 and headquartered in Brentwood, Tennessee, Surgery Partners offers high-quality, cost-effective surgical solutions across over 200 locations in 30 states, and utilizes its website as a key information resource.
Potential Positives
- Surgery Partners is scheduled to release its first quarter 2025 results, indicating ongoing financial transparency and the company’s commitment to keeping investors informed.
- The upcoming conference call on May 12, 2025, provides an opportunity for stakeholders to engage directly with company leadership, which can enhance investor relations.
- The company’s extensive network of over 200 locations in 30 states highlights its strong market presence and growth within the healthcare sector.
Potential Negatives
- Announcement of financial results on May 12, 2025, may precede expectations of poor performance, leading to potential investor concerns.
- The press release does not highlight any recent achievements or growth metrics, which could create an impression of stagnation in the company's progress.
- Exclusively focusing on upcoming events without addressing recent challenges or changes in the market may indicate a lack of transparency to investors.
FAQ
When will Surgery Partners release its first quarter 2025 results?
Surgery Partners will release its first quarter 2025 results on May 12, 2025, before the market opens.
How can I join the Surgery Partners conference call?
You can join the conference call by dialing 1-877-451-6152 (domestic) or 1-201-389-0879 (international).
Will the Surgery Partners conference call be available for replay?
Yes, the replay will be available three hours after the call until May 26, 2025.
Where can I find more information about Surgery Partners?
Additional information can be found on Surgery Partners' website at www.surgerypartners.com.
What is the focus of Surgery Partners’ business model?
Surgery Partners focuses on providing high-quality, cost-effective surgical and ancillary care solutions through its outpatient delivery model.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$SGRY Insider Trading Activity
$SGRY insiders have traded $SGRY stock on the open market 16 times in the past 6 months. Of those trades, 0 have been purchases and 16 have been sales.
Here’s a breakdown of recent trading of $SGRY stock by insiders over the last 6 months:
- HARRISON R. BANE (National Group President) has made 0 purchases and 2 sales selling 60,360 shares for an estimated $1,541,643.
- JASON ERIC EVANS (Chief Executive Officer) sold 26,520 shares for an estimated $680,238
- DAVID T DOHERTY (Chief Financial Officer) has made 0 purchases and 2 sales selling 20,374 shares for an estimated $511,072.
- MARISSA BRITTENHAM (Chief Strategy Officer) has made 0 purchases and 2 sales selling 17,856 shares for an estimated $452,495.
- JENNIFER BALDOCK (Chief Admin & Dev Officer) has made 0 purchases and 3 sales selling 9,301 shares for an estimated $233,493.
- WILLIAM TRENTON WEBB (American Group President) has made 0 purchases and 3 sales selling 2,452 shares for an estimated $59,366.
- DANIELLE BURKHALTER (Chief Human Resources Officer) has made 0 purchases and 3 sales selling 1,481 shares for an estimated $35,981.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$SGRY Hedge Fund Activity
We have seen 95 institutional investors add shares of $SGRY stock to their portfolio, and 92 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JANUS HENDERSON GROUP PLC added 6,057,477 shares (+110.2%) to their portfolio in Q4 2024, for an estimated $128,236,788
- WELLINGTON MANAGEMENT GROUP LLP removed 3,919,912 shares (-39.8%) from their portfolio in Q4 2024, for an estimated $82,984,537
- FMR LLC removed 2,030,004 shares (-11.1%) from their portfolio in Q4 2024, for an estimated $42,975,184
- DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) removed 1,780,287 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $37,688,675
- KING STREET CAPITAL MANAGEMENT, L.P. added 1,350,000 shares (+93.1%) to their portfolio in Q4 2024, for an estimated $28,579,500
- POINT72 ASSET MANAGEMENT, L.P. added 1,208,639 shares (+224.7%) to their portfolio in Q4 2024, for an estimated $25,586,887
- HEIN PARK CAPITAL MANAGEMENT LP added 1,139,227 shares (+inf%) to their portfolio in Q4 2024, for an estimated $24,117,435
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$SGRY Analyst Ratings
Wall Street analysts have issued reports on $SGRY in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Cowen & Co. issued a "Buy" rating on 11/14/2024
- Jefferies issued a "Buy" rating on 11/13/2024
To track analyst ratings and price targets for $SGRY, check out Quiver Quantitative's $SGRY forecast page.
$SGRY Price Targets
Multiple analysts have issued price targets for $SGRY recently. We have seen 2 analysts offer price targets for $SGRY in the last 6 months, with a median target of $35.5.
Here are some recent targets:
- Brian Tanquilut from Jefferies set a target price of $40.0 on 11/13/2024
- Andrew Mok from Barclays set a target price of $31.0 on 11/13/2024
Full Release
BRENTWOOD, Tenn., April 18, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its first quarter 2025 results before the market opens on Monday, May 12, 2025, to be followed by a conference call at 8:30 a.m. (Eastern Time).
You can join the call as follows:
- Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)
- Replay (available 3 hours after the call and available until May 26, 2025): 1-844-512-2921 (domestic), 1-412-317-6671 (international)
- Passcode for the live call and the replay: 13752904
Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company's website at
www.surgerypartners.com
. The replay will also be available on this same website for a limited time following the call.
To learn more about Surgery Partners, please visit the company's website at
www.surgerypartners.com
. Surgery Partners uses its website as a channel of distribution of material company information. Financial and other material information regarding Surgery Partners is routinely posted on the Company's website and is readily accessible.
About Surgery Partners
Headquartered in Brentwood, Tennessee, Surgery Partners is a leading healthcare services company with a differentiated outpatient delivery model focused on providing high-quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. Founded in 2004, Surgery Partners is one of the largest and fastest growing surgical services businesses in the country, with more than 200 locations in 30 states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices and urgent care facilities. For additional information, visit
www.surgerypartners.com
.
Contact:
Surgery Partners Investor Relations
(615) 234-8940
IR@surgerypartners.com
This article was originally published on Quiver News, read the full story.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
